Pharmaceutical Technology
February 02, 2005
Articles
29
2
Extrusion-spheronization and pellet compression are effective means of developing first-order kinetic, controlled-release drug delivery systems of azithromycin (AZI). The authors prepared, evaluated, and optimized AZI formulations and assessed the stability of the selected formulation under accelerated storage conditions.
February 02, 2005
Articles
29
2
The Impurity Profiling Group reviews stress testing according to regulatory guidance documents. The authors emphasize what should be considered for late clinical phases and for registration application dossiers.
February 02, 2005
Articles
29
2
The USP prepares for its quinquennial conference in March.
February 02, 2005
Articles
29
2
Too many players and threats to the main customer base challenge European dose manufacturers.
February 02, 2005
Articles
29
2
Pharmaceutical Science & Technology Innovations
February 02, 2005
Articles
29
2
Analytical instrument suppliers are developing manufacturing-tailored tools that are small, precise, and easy to use.
February 02, 2005
Articles
29
2
Concerns about risky medicines may reduce pressure to expand drug imports while boosting demand for more comparative analyses of therapies.
February 02, 2005
Articles
29
2
The United States Pharmacopeia should not change its philosophical position on singlet testing.